Nachrichten zu CROSSJECT

Startseite > Aktien > CROSSJECT > Nachrichten

CROSSJECT Aktie

Aktie

ISIN: FR0011716265 WKN: A1XEH4 Land Flagge FR

Frankreich

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

2,2725

EUR

+6,79 %

+0,1445 EUR

Letzter Kurs 19:43:02 Lang & Schwarz

Geldkurs

19:43:02

2,1350

EUR

501 STK

Briefkurs

19:43:02

2,4100

EUR

501 STK

CROSSJECT Aktie kaufen

Kauf

Verkauf

Neueste Nachrichten

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024 22.08.24 · globenewswire · CROSSJECT
Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE Epilepsy Rescue Treatment 19.08.24 · globenewswire · CROSSJECT
Crossject achieves key ZEPIZURE manufacturing milestone 18.07.24 · globenewswire · CROSSJECT
Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference 15.07.24 · globenewswire · CROSSJECT
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO Epinephrine 10.07.24 · globenewswire · CROSSJECT
Crossject elaborates on ZEPIZURE potential in light of landmark RAMPART study and its own, recently published, bioequivalence study 26.06.24 · globenewswire · CROSSJECT
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America 12.06.24 · globenewswire · CROSSJECT
Crossject announces highly successful closing of its €8 million rights offering 04.06.24 · globenewswire · CROSSJECT
Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy 30.05.24 · globenewswire · CROSSJECT
Crossject signs a geographic extension of ZEPIZURE commercialization agreement in Europe 02.05.24 · globenewswire · CROSSJECT
Crossject reports audited financial results for 2023 25.04.24 · globenewswire · CROSSJECT
Crossject trading on Euronext to resume as usual on Wednesday April 3 02.04.24 · globenewswire · CROSSJECT

1
2

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September ... 500 Leser
Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization ... 164 Leser

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September ... 500 Leser
Crossject obtains a financing up to €12 million, in two tranches 304 Leser
Crossject trading on Euronext to resume as usual on Wednesday April 3 244 Leser
Crossject provides strategic update on priorities for 2024 208 Leser
Crossject gender equality score reaches 96/100 in 2024 184 Leser
Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization ... 164 Leser
Crossject to present at Biotech Showcase on January 9 at 16: 30 PT 160 Leser
Crossject reports audited financial results for 2023 156 Leser
Crossject advances in its U.S. Strategy and reports Financial Results for 2023 152 Leser
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE 152 Leser